BIOTECHNOLOGY VALUE FUND L P - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for 89bio, Inc. (ETNB)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
89bio, Inc. Common Stock, par value $0.001 per share
Symbol
ETNB
Shares outstanding
120M shares
Disclosed Ownership
4.33M shares
Ownership
3.6%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:07 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 1.9% 2.23M 0 2.23M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 1.9% 2.23M 0 2.23M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 1.5% 1.8M 0 1.8M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 1.5% 1.8M 0 1.8M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.2% 224K 0 224K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.2% 224K 0 224K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 3.4% 4.03M 0 4.03M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 3.6% 4.33M 0 4.33M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 3.6% 4.33M 0 4.33M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 3.6% 4.33M 0 4.33M /s/ Mark N. Lampert Mark N. Lampert